The store will not work correctly when cookies are disabled.
4-Acetamido-5-cyclopropanecarboxamido-2-fluoro benzoic acid
ID: ALA571446
PubChem CID: 45271722
Max Phase: Preclinical
Molecular Formula: C13H13FN2O4
Molecular Weight: 280.26
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)Nc1cc(F)c(C(=O)O)cc1NC(=O)C1CC1
Standard InChI: InChI=1S/C13H13FN2O4/c1-6(17)15-11-5-9(14)8(13(19)20)4-10(11)16-12(18)7-2-3-7/h4-5,7H,2-3H2,1H3,(H,15,17)(H,16,18)(H,19,20)
Standard InChI Key: LJEAVQYWGNGCQK-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
-1.8997 -1.0022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6142 -1.4147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6142 -2.2397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8997 -2.6522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1853 -2.2397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1853 -1.4147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4708 -1.0022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2437 -1.4147 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.4708 -0.1772 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.8997 -0.1772 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.3287 -2.6522 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.0431 -2.2397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7576 -2.6522 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.0431 -1.4147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8997 -3.4772 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.1853 -3.8897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4708 -3.4772 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.1853 -4.7147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5978 -5.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7728 -5.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 10 1 0
2 3 1 0
3 11 1 0
5 6 2 0
11 12 1 0
6 1 1 0
12 13 2 0
1 2 2 0
12 14 1 0
6 7 1 0
4 15 1 0
3 4 2 0
15 16 1 0
7 8 1 0
16 17 2 0
19 18 1 0
20 19 1 0
18 20 1 0
7 9 2 0
4 5 1 0
16 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 280.26 | Molecular Weight (Monoisotopic): 280.0859 | AlogP: 1.83 | #Rotatable Bonds: 4 |
Polar Surface Area: 95.50 | Molecular Species: ACID | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.25 | CX Basic pKa: ┄ | CX LogP: 1.03 | CX LogD: -2.41 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.78 | Np Likeness Score: -1.49 |
References
1. Magesh S, Savita V, Moriya S, Suzuki T, Miyagi T, Ishida H, Kiso M.. (2009) Human sialidase inhibitors: design, synthesis, and biological evaluation of 4-acetamido-5-acylamido-2-fluoro benzoic acids., 17 (13): [PMID:19450982] [10.1016/j.bmc.2009.04.065] |